Effect of low-dose dexamethasone on patients with elevated early follicular phase progesterone level and pregnancy outcomes in IVF-ET treatment: A randomized controlled clinical trial.

Published in: Clinical endocrinology (2018)

Progesterone secretion can be suppressed by dexamethasone, and dexamethasone may sensitize the ovary to gonadotropin stimulation in IVF treatment. In addition, the cumulative live-birth rate was significantly higher in the DEX group than in controls, and the obstetric and neonatal outcomes support the safety of DEX treatment in IVF.

Keyphrases

low dose
pregnancy outcomes
high dose
pregnant women
metabolic syndrome
combination therapy
skeletal muscle
preterm birth